Follow the 株式会社リプロセル share price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares are listed on the JP market, under the oversight of EDINET (Japan FSA). Market capitalisation: €14.7bn. The latest transaction was reported on 7 September 2026 (Holding update). Among the most active insiders: Heights Capital Management, Inc.. Every trade is free.
14
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
42Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,167 of 29,062 companies
28.3
score / 100
Value
25
Quality
31
FCF yld-3.3%
Earn yld-4.0%
EV/EBITDA·
ROE-4.9%
Gross mgn45%
Net mgn-26%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Reprocell Inc. es una empresa japonesa que cotiza en el mercado XTKS, especializada en el desarrollo de tecnologías de reprogramación celular. Se centra en aplicaciones en medicina regenerativa y biotecnología.